Australia markets closed

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1100+0.0900 (+8.82%)
At close: 04:00PM EDT
1.1208 +0.01 (+0.97%)
After hours: 06:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 99.99M
Enterprise value 3.81M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.20
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.57

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-52.36%
S&P500 52-week change 322.55%
52-week high 33.1100
52-week low 30.9450
50-day moving average 31.2265
200-day moving average 31.2655

Share statistics

Avg vol (3-month) 3245.37k
Avg vol (10-day) 3342.21k
Shares outstanding 590.08M
Implied shares outstanding 690.08M
Float 852.12M
% held by insiders 17.72%
% held by institutions 164.28%
Shares short (14 June 2024) 42.96M
Short ratio (14 June 2024) 413.64
Short % of float (14 June 2024) 43.32%
Short % of shares outstanding (14 June 2024) 43.29%
Shares short (prior month 15 May 2024) 42.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 315 Apr 2019
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 315 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-56.24%
Return on equity (ttm)-112.05%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -95.75M
Net income avi to common (ttm)-97.92M
Diluted EPS (ttm)-1.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)97.31M
Total cash per share (mrq)1.08
Total debt (mrq)1.13M
Total debt/equity (mrq)1.35%
Current ratio (mrq)5.09
Book value per share (mrq)0.93

Cash flow statement

Operating cash flow (ttm)-75.28M
Levered free cash flow (ttm)-44.23M